Evidence map›Paper›PMID 28151933›Full record

ArticlePLoS neglected tropical diseases2017

Specific anti-glycan antibodies are sustained during and after parasite clearance in Schistosoma japonicum-infected rhesus macaques.

Y Y Michelle Yang, Xiao Hong Li, Katarzyna Brzezicka, Niels-Christian Reichardt, R Alan Wilson, Angela van Diepen, Cornelis H Hokke

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Deciphering theBiomolecules · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Anti-schistosomal immunity to core xylose/fucose in N-glycans.Frontiers in molecular biosciences · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Metazoan Parasite Vaccines: Present Status and Future Prospects.Frontiers in cellular and infection microbiology · 2018
    Review
  19. TLR Specific Immune Responses against Helminth Infections.Journal of parasitology research · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 4 countries.

Y Y Michelle YangDepartment of Parasitology, Leiden University Medical Center, Leiden, Netherlands.
Xiao Hong LiNational Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, and Key Laboratory of Parasitology and Vector Biology, Ministry of Health, Shanghai, China.
Katarzyna BrzezickaGlycotechnology Laboratory, CICbiomaGUNE, San Sebastian, Spain.
Niels-Christian ReichardtGlycotechnology Laboratory, CICbiomaGUNE, San Sebastian, Spain.
R Alan WilsonCentre for Immunology & Infection, Department of Biology, University of York, York, United Kingdom.
Angela van DiepenDepartment of Parasitology, Leiden University Medical Center, Leiden, Netherlands.
Cornelis H HokkeDepartment of Parasitology, Leiden University Medical Center, Leiden, Netherlands.ORCID 0000-0003-3545-7804
Leiden University Medical Center · NLCIC biomaGUNE · ESNational Institute for Parasitic Diseases · CNUniversity of York · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHuman immunity to Schistosoma infection requires many years of exposure, and multiple infections and treatments to develop. Unlike humans, rhesus macaques clear an established schistosome infection naturally at the same time acquiring immunity towards re-infection. In macaques, schistosome egg production decreases after 8 weeks post-infection and by week 22, physiological impairment of the worm caused by unclarified antibody-mediated processes is observed. Since strong antibody responses have been observed against schistosome glycan antigens in human and animal infections, we here investigate if anti-glycan antibodies are associated with immunity against schistosome infections in macaques.

methodsWe used a microarray containing a large repertoire of glycoprotein- and glycolipid-derived glycans from different schistosome life stages to analyse anti-glycan serum IgG and IgM from S. japonicum-infected macaques during the course of infection and self-cure. We also used an in vitro schistosomula assay to investigate whether macaque sera containing anti-glycan antibodies can kill schistosomula. CONCLUSIONS/SIGNIFICANCE: Antibody responses towards schistosome glycans at week 4 post-infection were dominated by IgM while IgG was high at week 8. The profound increase in IgG was observed mainly for antibodies towards a large subset of glycans that contain (multi-)fucosylated terminal GalNAcβ1-4GlcNAc (LDN), and Galβ1-4(Fucα1-3)GlcNAc (LeX) motifs. In general, glycans with a higher degree of fucosylation gave rise to stronger antibody responses than non-fucosylated glycans. Interestingly, even though many IgG and IgM responses had declined by week 22 post-infection, IgG towards O-glycans with highly fucosylated LDN motifs remained. When incubating macaque serum with schistosomula in vitro, schistosomula death was positively correlated with the duration of infection of macaques; macaque serum taken 22 weeks post-infection caused most schistosomula to die, suggesting the presence of potentially protective antibodies. We hypothesize that IgGs against highly fucosylated LDN motifs that remain when the worms deteriorate are associated with infection clearance and the resistance to re-infection in macaques.

Indexed as

AnimalsAntibodies, HelminthAntigens, HelminthGlycoproteinsGlycosylationHumansImmunoglobulin GMacaca mulattaPolysaccharidesSchistosoma japonicumSchistosomiasis japonicaAntibodies, HelminthAntigens, HelminthGlycoproteinsImmunoglobulin GPolysaccharides

Identifiers

PMID28151933
PMCPMC5308859
OpenAlexW2583425973

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.